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It was 1994 when physicians told us, that our two sons
- deaf from birth - will lose their eye sight also to
Usher, a rare genetic disease. With inspiring support
from motivated scientists, private equity, National- and
European Agencies we moved from fragmented basic
research in identifying the gene, the molecular mechan-
isms of the protein and the specific mutation to shared
objectives in disease specific research for a therapy. We
founded a Family-Foundation to finance our activities, a
medical device company to develop a retina implant, a
chip for the eye and worked in EU- and US organisa-
tions to bring science ahead, e.g. the Foundation Fight-
ing Blindness (FFB), Fondation Voir & Entendre, Pro
Retina Foundation. We have already identified a cell-
based treatment by a drug which, down the road, has
the potential to put on hold the progression of our son’s
disease.
Therefore we have focused our activity with a view to
strengthening research with the European TREATRUSH
project within FP-7 Health, participated in networks for
fund-raising and pursued tests to see, if the drug (PTC
124) will stop the degeneration process in the retina
with the assumption that what works in Duchenne dis-
ease will also work in Usher 1C, and raise awareness of
companies to invest in therapy with PTC 124 for
patients with nonsense mutations in retinal degenerative
diseases including Usher 1C. Unlike the early days we
see a clear road to a therapy and are planning clinical
trials with interdisciplinary teams. There is also a critical
mass of expertise and substantial management by a bio-
tech company for the benefit of all with Usher 1C. Yes,
we can.
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